top of page

Hepatology and Liver Safety Consulting, LLC provides expert hepatic safety and drug-induced liver injury (DILI) consulting to pharmaceutical and biotechnology companies throughout the drug development lifecycle, from preclinical research through post-marketing surveillance.
Founding co-chair of the IQ-DILI Initiative and co-chair of its Immunotherapy, Gene Therapy, and Pediatrics working groups.
.jpg)
bottom of page

.jpeg)